TABLE 01. KEY EXPERTS, NEUROLOGICAL BIOMARKERS MARKET
TABLE 02. TOTAL DIAGNOSTIC ALZHEIMER'S MARKET, BY DIAGNOSTIC TECHNIQUES, 2017-2025 ($MILLION)
TABLE 03. TOTAL DIAGNOSTIC PARKINSON'S MARKET, BY DIAGNOSTIC TECHNIQUES, 2017-2025 ($MILLION)
TABLE 04. STATISTICS FOR ALZHEIMER'S IN U.S.
TABLE 05. STATISTICS FOR ALZHEIMER'S IN EU5
TABLE 06. STATISTICS FOR ALZHEIMER'S IN REST OF EUROPE
TABLE 07. STATISTICS FOR ALZHEIMER'S IN CHINA
TABLE 08. STATISTICS FOR ALZHEIMER'S IN ASIA-PACIFIC
TABLE 09. STATISTICS FOR ALZHEIMER'S IN REST OF WORLD
TABLE 10. STATISTICS FOR PARKINSONS IN U.S.
TABLE 11. STATISTICS FOR PARKINSONS IN EU5
TABLE 12. STATISTICS FOR PARKINSONS IN REST OF EUROPE
TABLE 13. STATISTICS FOR PARKINSONS IN CHINA
TABLE 14. STATISTICS FOR PARKINSONS IN ASIA-PACIFIC
TABLE 15. STATISTICS FOR PARKINSONS IN REST OF WORLD
TABLE 16. NEUROLOGICAL BIOMARKERS MARKET FOR ALZHEIMERS, BY RGION, 2017-2025 ($MILLION)
TABLE 17. INDIVIDUALS DIAGNOSED WITH ALZHEIMER'S DISEASE IN EU5, 2012
TABLE 18. HUNGARY ALZHEIMER'S DISEASE PREVALENCE, BY AGE GROUP
TABLE 19. ESTIMATED COST INCURRED & NUMBER OF INDIVIDUALS WITH ALZHEIMERS DISEASE IN THE ASIA-PACIFIC REGION
TABLE 20. PREVALENCE OF ALZHEIMER'S DEMENTIA IN LATIN AMERICA, 2013
TABLE 21. NEUROLOGICAL BIOMARKERS MARKET FOR PARKINSONS, BY GEOGRAPHY, 2017-2025 ($MILLION)
TABLE 22. PREVALENCE OF PARKINSONS DISEASE IN ASIA-PACIFIC REGION, 2017
TABLE 23. PREVALENCE OF PARKINSONS DISEASE IN ASIA-PACIFIC REGION, 2017

LIST OF FIGURE

FIGURE 01. TOP WINNING STRATEGIES, BY YEAR, 2014-2018*
FIGURE 02. TOP WINNING STRATEGIES, 2014-2018* (%)
FIGURE 03. TOP WINNING STRATEGIES, BY COMPANY, 2014-2018*
FIGURE 04. DIAGNOSTIC MARKET SIZE FOR ALZHEIMERS, 2017-2025 ($MILLION)
FIGURE 05. DIAGNOSTIC MARKET SIZE FOR PARKINSON'S, 2017-2025 ($MILLION)
FIGURE 06. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 07. HIGH BARGAINING POWER OF BUYERS
FIGURE 08. MODERATE THREAT OF SUBSTITUTION
FIGURE 09. MODERATE THREAT OF NEW ENTRANT
FIGURE 10. MODERATE COMPETITIVE RIVALRY
FIGURE 11. DRIVERS, RESTRAINTS, AND OPPORTUNITY: NEUROLOGICAL BIOMARKERS MARKET FOR ALZHEIMERS (AD) AND PARKINSONS (PD) DISEASES
FIGURE 12. PROJECTED NUMBER OF INDIVIDUALS IN THE U.S. WITH ALZHEIMERS, 2010 TO 2050
FIGURE 13. ALZHEIMER'S DISEASE BIOMARKERS MARKET IN U.S.
FIGURE 14. ALZHEIMER'S DISEASE BIOMARKERS MARKET IN EU5
FIGURE 15. ALZHEIMER'S DISEASE BIOMARKERS MARKET IN REST OF EUROPE
FIGURE 16. NUMBER OF INDIVIDUALS IN CHINA WITH ALZHEIMERS, 1990 TO 2010
FIGURE 17. ALZHEIMER'S DISEASE BIOMARKERS MARKET IN CHINA
FIGURE 18. ALZHEIMER'S DISEASE BIOMARKERS MARKET IN ASIA-PACIFIC
FIGURE 19. ALZHEIMER'S DISEASE BIOMARKERS MARKET IN ROW
FIGURE 20. PARKINSONS DISEASE BIOMARKERS MARKET IN U.S.
FIGURE 21. PARKINSONS DISEASE BIOMARKERS MARKET IN EU5
FIGURE 22. PARKINSONS DISEASE BIOMARKERS MARKET IN REST OF EUROPE
FIGURE 23. PARKINSONS DISEASE BIOMARKERS MARKET IN CHINA
FIGURE 24. PARKINSONS DISEASE BIOMARKERS MARKET IN ASIA-PACIFIC
FIGURE 25. PARKINSONS DISEASE BIOMARKERS MARKET IN ROW